Home>
US Stocks>
Ars Pharmaceuticals Inc

Ars Pharmaceuticals Inc share price today

(SPRY)

Ars Pharmaceuticals Inc share price is $14.02 & ₹1,187.35 as on 7 Dec 2024, 2.30 'hrs' IST

$14.02

▲

0.02

(0.14%)

Market is closed - opens 8 PM, 09 Dec 2024

View live Ars Pharmaceuticals Inc share price in Dollar and Rupees. Guide to invest in Ars Pharmaceuticals Inc from India. Also see the sentimental analysis on Indian investors investing in Ars Pharmaceuticals Inc. Get details on the Indian mutual funds that are investing in Ars Pharmaceuticals Inc. Get Analyst recommendations and forecasts along with all the Ars Pharmaceuticals Inc's financials.

Ars Pharmaceuticals Inc share price movements

$13.94
$14.48
$14.02
0.6%
Downside
Day's Volatility :3.72%
Upside
3.14%
$5.01
$18.51
$14.02
64.27%
Downside
52 Weeks Volatility :72.93%
Upside
24.26%

Ars Pharmaceuticals Inc Returns

Period	Ars Pharmaceuticals Inc	Index (Russel 2000)
3 Months	19.56%	0.0%
6 Months	54.36%	0.0%
1 Year	172.9%	0.0%
3 Years	102.6%	-21.5%

Ars Pharmaceuticals Inc Key Statistics

in dollars & INR

Previous Close	$14.0
Open	$14.0
Today's High	$14.475
Today's Low	$13.936
Market Capitalization	$1.4B
Today's Volume	$879.1K
52 Week High	$18.51
52 Week Low	$5.01
Revenue TTM	$2.6M
EBITDA	$-60.4M
Earnings Per Share (EPS)	$-0.5
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-22.41%

How to invest in Ars Pharmaceuticals Inc from India?

It is very easy for Indian residents to invest directly in Ars Pharmaceuticals Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Ars Pharmaceuticals Inc stock in both rupees (INR) and dollars (USD). Search for Ars Pharmaceuticals Inc or SPRY on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Ars Pharmaceuticals Inc or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Ars Pharmaceuticals Inc shares which would translate to 0.060 fractional shares of Ars Pharmaceuticals Inc as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Ars Pharmaceuticals Inc

-45%

Period: Sep 8, 2024 to Dec 7, 2024. Change in 30 Days versus previous period

Search volume for Ars Pharmaceuticals Inc on INDmoney from India has reduced in the last 30 days as on Dec 8, 2024. -45% less investors are searching Ars Pharmaceuticals Inc in the last 30 days versus the previous period.

Global Institutional Holdings in Ars Pharmaceuticals Inc

Deerfield Management Co
11.40%
RA Capital Management, LLC
11.18%
Orbimed Advisors, LLC
8.53%
BlackRock Inc
4.20%
SR ONE CAPITAL MANAGEMENT, LP
4.13%
Vanguard Group Inc
3.45%

Analyst Recommendation on Ars Pharmaceuticals Inc

Buy

88%Buy

11%Hold

0%Sell

Based on 9 Wall street analysts offering stock ratings for Ars Pharmaceuticals Inc(by analysts ranked 0 to 5 stars)

Based on 9 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Ars Pharmaceuticals Inc

What analysts predicted

Upside of 89.02%

Current:

$14.02

Target:

$26.50

Insights on Ars Pharmaceuticals Inc

Increasing Revenue
Revenue is up for the last 3 quarters, -30.0K → 2.06M (in $), with an average increase of 90.9% per quarter
Decreasing Net Profit
Netprofit is down for the last 4 quarters, -7.16M → -19.12M (in $), with an average decrease of 39.3% per quarter

Ars Pharmaceuticals Inc Technicals Summary

Sell

Neutral

Buy

Ars Pharmaceuticals Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Ars Pharmaceuticals Inc Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Ars Pharmaceuticals Inc	-17.84%	54.36%	172.9%	102.6%	-44.0%
Regeneron Pharmaceuticals, Inc.	-6.86%	-23.34%	-9.49%	15.35%	108.86%
Biontech Se	10.16%	21.29%	18.26%	-58.19%	324.43%
Alnylam Pharmaceuticals, Inc.	-7.5%	64.08%	47.33%	46.0%	106.67%
Vertex Pharmaceuticals Incorporated	-8.46%	-4.83%	29.09%	120.68%	108.8%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Ars Pharmaceuticals Inc	NA	NA	NA	-0.54	-0.22	-0.16	NA	2.07
Regeneron Pharmaceuticals, Inc.	18.56	18.56	1.12	44.92	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.06	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.21	0.54	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Ars Pharmaceuticals Inc	Buy	$1.4B	-44.0%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$82.9B	108.86%	18.56	33.61%
Biontech Se	Buy	$28.5B	324.43%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$32.7B	106.67%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$118.4B	108.8%	32.84	-4.51%

About Ars Pharmaceuticals Inc

silverback therapeutics is a biotechnology company that was founded in 2016. the company is based in seattle, wa and is funded by orbimed.

Organization	Ars Pharmaceuticals Inc
Employees	24
CEO	Mr. Richard Lowenthal M.B.A., M.S., MSMSEL
Industry	Healthcare

Management People of Ars Pharmaceuticals Inc

Name	Title
Mr. Richard Lowenthal M.B.A., M.S., MSMSEL	Founder, President, CEO & Director
Dr. Sarina Tanimoto M.B.A., M.D.	Co-Founder & Chief Medical Officer
Mr. Alexander A. Fitzpatrick Esq.	Chief Legal Officer & Secretary
Dr. Robert Bell Ph.D.	Co-Founder & Chief Science Officer
Ms. Kathleen D. Scott CPA	Chief Financial Officer
Mr. Brian T. Dorsey M.S.	Chief Operations Officer
Mr. Daniel Relovsky	Senior Vice President of Marketing
Mr. Harris Kaplan M.B.A.	Executive Vice President of Commercial Strategy
Mr. Eric Karas	Chief Commercial Officer
Mr. Justin Chakma	Chief Business Officer & Secretary

Important FAQs about investing in Ars Pharmaceuticals Inc from India :

What is Ars Pharmaceuticals Inc share price today?

Ars Pharmaceuticals Inc (SPRY) share price today is $14.02.

Can Indians buy Ars Pharmaceuticals Inc shares?

Yes, Indians can invest in the Ars Pharmaceuticals Inc (SPRY) from India.

With INDmoney, you can buy Ars Pharmaceuticals Inc at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Ars Pharmaceuticals Inc at zero transaction cost.

How can I buy Ars Pharmaceuticals Inc shares from India?

It is very easy to buy Ars Pharmaceuticals Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Ars Pharmaceuticals Inc be purchased?

Yes, you can buy fractional shares of Ars Pharmaceuticals Inc with INDmoney app.

What are the documents required to start investing in Ars Pharmaceuticals Inc stocks?

To start investing in Ars Pharmaceuticals Inc, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.